Profile
IP Group is a venture capital firm based in the United Kingdom, established in 2001. The firm was founded with the aim to commercialize scientific research from UK universities by investing in ventures with strong potential for impact. Over the years, IP Group has grown its team to include experts in science, entrepreneurship, and investment, enabling them to efficiently support the development of pioneering technologies. Their unique approach lies in their close collaborations with academic institutions and deep focus on technology-based enterprises.
The firm focuses its investments on science and technology sectors, including biotechnology, pharmaceuticals, materials, energy, and sustainability. The firm invests in all stages from pre-seed to Series B, primarily within the UK, but also extends its reach to scalable opportunities in international markets. Their total assets under management have not been disclosed as of now.
Notable investments by IP Group include Oxford Nanopore Technologies - a company providing scalable DNA sequencing technology, Ceres Power - fuel cell technology, and Diurnal Group - focused on hormone-derived therapeutics.
Industry
IP Group Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
IP Group Climate Catalyst Fund
|
Venture Capital (VC)
|
ClimateTech
Mobility
HealthTech
Energy
Life Sciences
AI
Transportation
Telecommunications
Software
Security
Robotics
Pharmaceuticals
Other
Media and Entertainment
Marketing and Advertising
IT Services
Healthcare Services
Fintech
Financial Services
Biotechnology
|
Series A
Seed
Pre-seed
Series B
|
North America
Europe
Asia
|
$1-5 m
|
—
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.